Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is in metoprolol?Xarelto clinical trials near me?How much is lisinopril without insurance?Budesonide manufacturer?Theophylline manufacturer?
See the DrugPatentWatch profile for Trazodone
Trazodone, an antidepressant medication, has had its primary patents expire. The composition of matter patent for trazodone expired in the early 1990s [1].
While the original patent has expired, there may be other patents related to specific formulations, manufacturing processes, or new uses of trazodone that could still be in effect. However, these secondary patents generally do not prevent generic versions of the original drug from being produced once the main patent lapses [2].
The expiration of patents is a key factor enabling the production of generic versions of a drug. Once patents expire, other pharmaceutical companies can manufacture and sell their own versions of trazodone, often at a lower cost [2]. This process increases market competition and can lead to significant price reductions for patients and healthcare systems.
With trazodone being off-patent, it is widely available as a generic medication. This accessibility allows for more affordable treatment options for individuals managing depression and insomnia [1]. Generic drugs must meet the same quality and efficacy standards as their brand-name counterparts [2].
Other Questions About Trazodone :